Read + Share
Amedeo Smart
Independent Medical Education
Han M, Yamaguchi S, Onishi M, Fujii T, et al. The MDM2 and CDKN2A Copy-number-variation Influence the TP53-signature-score in Wild-type TP53 Luminal Type Breast Cancer. Anticancer Res 2022;42:2277-2288.PMID: 35489754
Email
LinkedIn
Facebook
Twitter
Privacy Policy